What is AMR and What is the Big Deal About it?

Dr Sanchia Warren1

1Infectious Diseases Physician and Microbiologist – Tasmanian Health Service, Clinical Senior Lecturer – UTAS

Biography:

Dr Sanchia Warren is an Infectious Diseases Physician and Medical Microbiologist for the Tasmanian Health Service and Clinical Senior Lecturer at the University of Tasmania.  Her interests lie in Antimicrobial Stewardship where she is the Clinical Lead for AMS in Tasmania as well as having roles on national AMS groups.  She has been involved in the development of the NSQHC Sepsis Clinical Care Standards and more recently Therapeutic Guidelines Antibiotic. In her laboratory role she was a co-author RCPA Cascade Reporting Guidelines for laboratories and AUSCAST, for the at interpretation and reporting of antimicrobial susceptibilities.

Abstract:

AMR or Antimicrobial Resistance is a rising global health threat. This session will provide an overview on AMR, its mechanisms and its drivers. The implications of increasing AMR both in a local setting and globally will highlight why AMR is becoming an increasingly big deal.

 

Categories